Due to maintenance work, this service will be unavailable from
Mon Nov 11 17:30 until
Tue Nov 12 09:00
CET.
Apologies for the inconvenience.
Cellosaurus publication CLPUB00701
Publication number | CLPUB00701 |
---|---|
Authors | Gioanni J., Mazeau C., Zanghellini E., Milano G., Fischel J.-L., Turc-Carel C., Schneider M. |
Title | Establishment of two human cell lines from the same patient suffering from mammary adenocarcinoma and differentially expressing the MDR gene. |
Citation | Bull. Cancer 80:472-472(1993) |
Abstract | We describe a representative cellular model of MDR resistance developed in a patient with breast adenocarcinoma. This model consists of two cell lines CAL 85-1 and CAL 85-2. CAL 85-1 comes from the primary tumor after first chemotherapy (adriamycin, 5-FU, cyclophosphamide). CAL 85-2 is obtained 9 months later, following adjuvant chemotherapy (5-FU, epirubicin, cyclophosphamide) and heavy chemotherapy (melphalan) before auto-grafting of bone marrow, from a chest recurrence. We give the morphological and cytogenetic characteristics of these two lines. For this model, MDR expression was measured by cytofluorimetry at using monoclonal antibodies C 219, JSB 1 and MRK 16. Only the latter shows a difference in MDR expression in favor of CAL 85-2. The efficacy of 3 MDR reversants, verapamil, cyclosporine and S 9788 is consistent with a moderate difference in MDR expression between CAL 85-1 and CAL 85-2. This cellular system seems closer to reality clinical than those previously established in vitro by artificial selective pressure. |
Cell lines | CVCL_1114; CAL-85-1 CVCL_B7MJ; CAL-85-2 |